Sanofi to invest 1.3 bln euros in new insulin plant in Frankfurt

French drugmaker Sanofi (SASY.PA) will invest 1.3 billion euros ($1.40 billion) in a new insulin production facility at its existing site in Frankfurt, where it makes insulin brand Lantus, the company said on Thursday.